Miramoon Pharma
San Sebastian
About Miramoon Pharma
Miramoon Pharma is a biotechnology company based in San Sebastián, Spain, that develops first-in-class small-molecule medicines targeting musculoskeletal, cardiovascular, and neurodegenerative diseases, including rare genetic conditions. The company’s lead programs focus on stabilizing calcium channels and reducing oxidative stress, with its main candidate, MP-004, advancing preclinical studies for inherited retinal disorders like retinitis pigmentosa. Miramoon’s pipeline also includes candidates for conditions such as Duchenne muscular dystrophy, myotonic dystrophy type 1, ALS, and Alzheimer’s disease.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: miramoonpharma.com
- Phone: [email protected]
Industries & Categories
Big Data, Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/miramoon-pharma-2700775 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.